TWO SIGMA INVESTMENTS, LP - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$189,314
-78.5%
149,066
-44.2%
0.00%
-50.0%
Q2 2023$879,318
+4.6%
267,270
+30.6%
0.00%0.0%
Q1 2023$840,840
-76.8%
204,584
-66.9%
0.00%
-81.8%
Q4 2022$3,620,478
-21.5%
617,829
-9.4%
0.01%
-31.2%
Q3 2022$4,611,000
+121.3%
682,082
+51.2%
0.02%
+128.6%
Q2 2022$2,084,000
-59.1%
451,174
-64.6%
0.01%
-53.3%
Q1 2022$5,090,000
-6.8%
1,275,634
+45.3%
0.02%
+25.0%
Q4 2021$5,460,000
+66.3%
877,752
+152.1%
0.01%
+71.4%
Q3 2021$3,284,000
-57.1%
348,245
-38.3%
0.01%
-58.8%
Q2 2021$7,660,000
+22.8%
564,030
+46.3%
0.02%
+6.2%
Q1 2021$6,239,000
+18.2%
385,570
+94.4%
0.02%
+6.7%
Q4 2020$5,278,000
+69.0%
198,333
+18.2%
0.02%
+36.4%
Q3 2020$3,124,000
-39.2%
167,767
-23.5%
0.01%
-56.0%
Q2 2020$5,134,000
+1056.3%
219,386
+188.0%
0.02%
+525.0%
Q1 2020$444,000
+152.3%
76,188
+148.2%
0.00%
+300.0%
Q4 2019$176,000
-4.3%
30,699
-73.7%
0.00%0.0%
Q3 2019$184,000
+53.3%
116,660
+293.7%
0.00%
Q2 2019$120,000
-66.9%
29,628
-56.9%
0.00%
-100.0%
Q1 2019$362,000
+30.7%
68,791
+1.3%
0.00%0.0%
Q4 2018$277,00067,9250.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 5,000,000$6,350,0001.92%
VR Adviser, LLC 11,328,000$14,386,5601.51%
Bain Capital Life Sciences Investors, LLC 8,663,673$11,002,8651.23%
Affinity Asset Advisors, LLC 2,850,000$3,619,5001.02%
EcoR1 Capital, LLC 19,364,688$24,593,1540.83%
Altium Capital Management LP 1,059,136$1,345,1030.70%
5AM Venture Management, LLC 1,305,000$1,657,3500.48%
Decheng Capital Management III (Cayman), LLC 904,268$1,148,4200.38%
COMMODORE CAPITAL LP 2,244,378$2,850,3600.33%
Philosophy Capital Management LLC 2,342,634$2,975,1450.32%
View complete list of MERSANA THERAPEUTICS INC shareholders